v3.26.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Current assets    
Cash and cash equivalents $ 396,225 $ 429,474
Receivables, net (including amounts from related parties) 530,889 374,465
Income taxes receivable 0 1,799
Other receivables 20,384 26,385
Prepaid expenses and other current assets 29,348 26,264
Loans receivable 3,128 4,926
Total current assets 979,974 863,313
Non-current assets    
Property and equipment, net 66,103 57,332
Intangible assets, net 229,533 270,968
Goodwill 889,390 865,305
Income taxes receivable, net of current portion 26,220 26,220
Loans receivable, net of current portion 49,374 48,724
Investments in other entities – equity method 27,015 25,637
Operating lease right-of-use assets 48,308 35,738
Other assets 27,515 25,424
Total non-current assets 1,363,458 1,355,348
Total assets [1] 2,343,432 2,218,661
Current liabilities    
Accounts payable and accrued expenses 272,541 195,912
Fiduciary accounts payable 3,694 3,524
Income taxes payable 2,561 0
Medical liabilities 418,181 335,705
Operating lease liabilities 10,612 7,809
Current portion of long-term debt 59,831 47,865
Other liabilities 18,648 24,458
Total current liabilities 786,068 615,273
Non-current liabilities    
Deferred tax liability 7,635 5,491
Operating lease liabilities, net of current portion 41,392 31,552
Long-term debt, net of current portion and deferred financing costs 865,546 990,904
Other long-term liabilities 11,290 17,107
Total non-current liabilities 925,863 1,045,054
Total liabilities [1] 1,711,931 1,660,327
Commitments and contingencies (Note 11)
Mezzanine deficit    
Non-controlling interest in Allied Physicians of California, a Professional Medical Corporation ("APC") (236,801) (234,962)
Stockholders’ equity    
Preferred stock, $0.001 par value per share; 5,000,000 shares authorized, and zero shares issued and outstanding as of September 30, 2026 and December 31, 2025 0 0
Common stock, $0.001 par value per share; 100,000,000 shares authorized, 49,320,378 and 48,885,358 shares issued and outstanding, excluding 10,724,258 and 10,571,011 treasury shares, as of September 30, 2026 and December 31,2025, respectively 49 49
Additional paid-in capital 501,366 470,863
Retained earnings 355,204 308,379
Total stockholders’ equity 856,619 779,291
Non-controlling interests 11,683 14,005
Total equity 868,302 793,296
Total liabilities, mezzanine deficit, and stockholders' equity $ 2,343,432 $ 2,218,661
[1] The Company’s condensed consolidated balance sheets include the assets and liabilities of its consolidated VIEs. The condensed consolidated balance sheets include (a) total assets of $1,314.6 million and $1,276.5 million as of September 30, 2026 and December 31, 2025, respectively, that can be used only to settle obligations of the Company’s consolidated VIEs and (b) total liabilities of the consolidated VIEs of $382.6 million and $376.0 million as of September 30, 2026 and December 31, 2025, respectively, for which creditors do not have recourse to the general credit of Astrana Health, Inc., the VIE’s primary beneficiary. These VIE balances do not include $218.1 million of investment in affiliates and $8.6 million of amount due to affiliates as of September 30, 2026 and $152.2 million of investment in affiliates and $58.3 million of amount due from affiliates as of December 31, 2025, as these are eliminated upon consolidation and not presented within the condensed consolidated balance sheets. See Note 15 — “Variable Interest Entities (VIEs)” for further details.

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Source

10-Q PDF
XBRL